Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-20-005890
Filing Date
2020-05-08
Accepted
2020-05-08 09:00:17
Documents
2
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20200507xdefa14a.htm DEFA14A 51365
2 GRAPHIC tmb-20200507xdefa14ag001.jpg GRAPHIC 4987
  Complete submission text file 0001558370-20-005890.txt   59380
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36177 | Film No.: 20858918
SIC: 2834 Pharmaceutical Preparations